(Reuters) A Fulton Hotshot lights a controlled burn on the so-called Sequoia Fund, the large mutual fund managed by Robert Goldfarb and David Poppe, has posted a letter on the homepage of its website defending its massive investment in Valeant ... Yahoo! UK and Ireland, 1 month ago
A huge fund has defended a massive investment in Valeant that has caused an 'extraordinary amount of pain' - Business Insider India, 1 month ago
Valeant's largest shareholder has said the company's share price slide has caused an 'extraordinary amount of pain' - Yahoo! Singapore, 1 month ago
1 images for "robert citron"
MONTREAL -- Embattled drugmaker Valeant Pharmaceuticals is asking U.S. securities regulators to investigate Citron Research, whose explosive report about the Quebec-based company's business practices caused its stock to crater. Chief executive ...CTV News, 1 month ago Valeant asks SEC to investigate Citron Research Advisor.ca, 1 month ago Valeant Calls for SEC Investigation Into Citron's Actions NewsMax.com, 1 month ago Drugmaker Valeant raises detailed defense but doubts remain Sharenet, 1 month ago
Summary Valeant's stock has fallen over 30% since Citron Research raised issues over its accounting and revenue recognition practices. Valeant gave narrow responses to issues raised by Citron. R&O disputed a $69MM invoice that Valeant has ...Seeking Alpha, 1 month ago
Summary I discuss the performance of my portfolio. Valeant to appoint a committee to review Citron's allegations. FDA issues CRL in response to Spectrum's Evomela NDA. (This digest has multiple sections, a few of which are shown below.Seeking Alpha, 1 month ago
Reuters The participants on the call include CEO Michael Pearson, general counsel Robert Chai-Onn, Chief Financial Officer Robert Rosiello, and a number of board and risk-committee members. Ten Valeant executives will be on the call. ...Business Insider, 1 month ago Valeant CEO rejects fraud accusations in conference call Pharmafile, 1 month ago Valeant is holding an all-hands on deck call to address allegations made by a short seller BusinessInsider.co.id, 1 month ago
(RTTNews.com) - Michael Pearson, Chairman and Chief Executive Officer of Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) said that sensational claims made by the short-seller Andrew Left through his entity Citron are completely untrue. His ...Nasdaq, 1 month ago Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant Pharmaceuticals Barchart, 1 month ago VALEANT PHARMACEUTICALS INTL : Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant Pharmaceuticals 4 Traders, 1 month ago Statements Of Chairman And CEO, And Lead Outside Director Of Valeant BioSpace, 1 month ago
The board committee will be chaired by the Canadian company's lead outside director, Robert Ingram. Valeant said last week that it had purchased an option late last year to buy Philidor. The short seller research firm Citron said in a report ...Investor's Business Daily, 1 month ago Valeant Board Committee Looking Into Philidor Ties Investor's Business Daily, 1 month ago Canada's largest drug company to investigate reports of fake sales CTV News, 1 month ago Valeant Pharma board forms committee to look into drug company's ties to Philidor 570News, 1 month ago
Sequoia Fund recently increased its stake in Valeant and bought into Allergan which is surprising given the controversial nature of these positionsCheck out Warren Buffett Stock Picks » Download GuruFolio Report of Warren Buffett (Updated on ...MyInforms, 1 week ago
Is Biogen Idec Inc. (NASDAQ: BIIB ) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days of research on it. Given their 2 and 20 payment structure, hedge funds ...InsiderMonkey.com, 13 hours ago Is Autohome Inc (ADR) (ATHM) A Good Stock To Buy? InsiderMonkey.com, 2 days ago Elite Investors Are Growing Bullish On Ralph Lauren Corp (RL) InsiderMonkey.com, 1 week ago
The equity market returns were very disappointing in the third quarter, thanks to the slowdown of China's economy and the weaker-than-expected U.S. economic data. It was not entirely clear whether the broader market sell-off made U.S. equity ...InsiderMonkey.com, 1 day ago Is Pfizer Inc. (NYSE:PFE) Going to Burn These Hedge Funds? InsiderMonkey.com, 1 week ago
on your WebpageAdd Widget >Get your members hooked!